Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant P-selectin glycoprotein immunoglobulin

EU orphan designation number: EU/3/06/376   
Active ingredient: Recombinant P-selectin glycoprotein immunoglobulin
Indication: Prevention of post transplantation graft dysfunction
Sponsor: RJM Consultancy Ltd
Alresford House, 60 West Street, Farnham, Surrey, GU9 7EH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/05/2006 Orphan designation EMEA/OD/008/06 (2006)2145 of 22/05/2006